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Herbal remedies are widely used for the treatment and prevention of various diseases and often contain
highly active pharmacological compounds. Many medicinal herbs and pharmaceutical drugs are
therapeutic at one dose and toxic at another. Toxicity related to traditional medicines is becoming more
widely recognized as these remedies become popular in the Mediterranean region as well as worldwide.
Most reports concerning the toxic effects of herbal medicines are associated with hepatotoxicity
although reports of other toxic effects including kidney, nervous system, blood, cardiovascular and
dermatologic effects, mutagenicity and carcinogenicity have also been published in the medical
literature. This article presents a systematic review on safety of traditional Arab medicine and the
contribution of Arab scholars to toxicology. Use of modern cell biological, biochemical, in vitro and
in vivo techniques for the evaluation of medicinal plants safety is also discussed.
Keywords: Arab herbal medicine – complementary and alternative medicine (CAM) – in vitro –
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Introduction
Parallel with recent increasing interest in alternative/herbal
medicine for the prevention and treatment of various illnesses,
there is increasing concern about the safety of medicinal
plants. There are general and herb-specific concerns regarding
medicinal plants and their ability to produce toxicity and
adverse effects. Accidental herbal toxicity occurs not only as a
result of a lack of pharmaceutical quality control in harvesting
and preparation, but also because herbal remedies are believed
to be harmless. Furthermore, a confusing nomenclature and
lack of quality control and the accurate identification of plants
are important concerns. There are no governmental regulations
on the manufacture, purity, concentration, or labeling claims
of herbal remedies and dietary supplements. The concentra-
tion, sample preparation, and the long-term stability of active
compounds and other chemicals in plants varies by the part of
the plant harvested and sold, and the maturity of the plant at the
time of harvest. In addition, geography, soil composition and
its contaminants, and year-to-year variations in soil acidity,
water, weather conditions, and other growth factors have
significant effects on the pharmaceutical properties of the
medicinal plants. Therefore, the actual dose of active
compounds being consumed is often variable, unpredictable
or simply unknown. When compared with adults, children may
be particularly susceptible to the effects of such dosage
variations due to their smaller size and different capacity for
detoxifying chemicals.
Early Arabic/Islamic Works on Poisons and Antidotes
Origins of the discussion on poisons and antidotes date back to
the Greeks and Indians, as well as to the empiric knowledge of
the indigenous population in the Arabic/Islamic world. One of
the most important scholarly contributions is The Book on
Poisons and Antidotes by the famous Arab alchemist, Abu
Musa Jabir ben Hayyan. Based in Kufa, Iraq, he established
himself as one of the leading scientists practicing medicine and
alchemy in the eighth century. In the six chapters of his book,
he identifies poisons by their traits and natural origins, modes
of action, dosages, methods of administration and choice of
drugs. He also identifies the target organ attacked by each
poison, a proposition that is modern in its chemotherapeutic
application.
Another example of an independent manual on toxicology is
Kitab as-Sumum, written in five volumes by Shanaq, the
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al-Jawhari in the ninth century. The work discusses how
various poisons could be detected by sight, touch, taste or by
toxic symptoms developed during the treatment. A similar
analysis is found in a later book on toxicology by Ibn
Wahshiyyah during the early tenth century. Many of the
antidotesdescribed byArabscientists,likeAbuMusa Jabirben
Hayyan and Ibn Wahshiyyah, are still used today by herbalists
in our region (Table 1).
Herbal Medicine in the Mediterranean Region
Current Status
The Eastern region of the Mediterranean has been distin-
guished throughout the generations with a rich inventory of
natural medicinal herbs used by local herbalists (1–8). A recent
survey conducted by our group found only 31 professional
Arab practitioners in Israel, Palestine and the Golan Heights
still practicing their careers (9). This number is significantly
less in comparison to the number of previous surveys (4,10).
Each practitioner has his own methods of preparation,
following his parent or teacher’s tradition. A limited exchange
of information takes place between healers in the same area.
Furthermore, the data reveal that there is no systematic
instruction of the next generation of healers, and that children
of the practitioners have no interest in the subject. The
knowledge and practice of traditional healing is a family
matter and passed on by inheritance.
Knowledge of the Safety of Medicinal Plants
Based on results obtained from recent studies (4,9,11), the
status of the knowledge of the safety and efficacy of medicinal
plants used in our region can be summarized as follows:
(i) Most practitioners have very limited training and
knowledge. Some practitioners have even turned to ‘mystical’
or ‘magical methods of healing’. (ii) Related to this, traditional
knowledge is not being passed down from generation to
generation, as in the past. (iii) Lack of pharmaceutical quality
control in harvesting and preparation procedures for medicinal
remedies. Practitioners today buy readymade or partially
prepared remedies from ‘Attarah’ shops, where plant materials
are sold, rather than collecting the plants directly from nature.
(iv) Plants used in certain regions are not used in others. For
example, local practitioners from the Negev region of Israel
use plant species found in the desert, overlooking plant
varieties and knowledge spanning the entire Middle Eastern
region.
Safety Concerns of Herbal Remedies
Toxicity of medicinal plants may be related to the mixtures of
active compounds that they contain; their interactions with
other herbs and drugs, contaminants, adulterants; or their
inherent toxicity (Fig. 1). Plants have complex mixtures of
terpenes, alkaloids, saponins and other chemicals, increasing
the risk of adverse reactions to any one of them or to the
additive or synergistic effects of chemical interactions. For
example, more than 100 chemicals have been identified in tea
tree oil (12).
There are general and herb-specific concerns regarding
toxicity and adverse effects. A confusing nomenclature and
issues of quality control and the accurate identification of
plants are important concerns. The common names of plants
and herbal remedies can be outdated and variable depending
on the geographic region (8,9). There is no governmental
regulation on the manufacture, purity, concentration or
labeling claims of herbal remedies and dietary supplements.
Thus, it is always ‘buyer beware’ in this marketplace.
Dosage of the Active Compounds
The concentration of active ingredients and other chemicals in
plants varies by the part of the plant harvested and sold; the
maturity of the plant at the time of harvest; the time of year
during harvest; geography and soil conditions; soil composi-
tion and its contaminants; and year-to-year variations in soil
acidity, water, weather conditions and other growth factors.
For example, Azaizeh and his co-workers (13) have reported in
a recent study that fertilization affects the antioxidant activity
of four medicinal plants used in traditional Arab medicine.
They found that increasing the amount of fertilizer caused a
significant concentration-dependent increase in antioxidant
activity of cultivated Teucrium polium compared with the
wild-type. In contrast, increasing the amount of fertilizer
caused a significant concentration-dependent reduction in the
antioxidant activity of powders prepared from cultivated
Eryngium creticum when compared with wild plants. There-
fore, the actual dose of active ingredients being consumed is
often variable, unpredictable or simply unknown (14). Dosage-
variation has greater effects on children due to their smaller
size and different capacity for detoxifying chemicals (14,15).
Table 1. Poisons and antidotes used in the traditional Arab medicine
Poison Antidotes
Lead Neuseant and then treatment with water
extracts from seeds of Ficus carica
(wild fig tree), Apium graveolens
(wild celery), Anethum graveolens (dill),
and then water extracts from Smilax
officinalis (Sarsaparilla), Triticum vulgare
(common wheat), Hyssopus officinalis
(common hyssop)
Mercury Neuseant and then treatment with water
extracts of Smilax officinalis
(Sarsaparilla) mixed with honey
Iron Rosa canina (dog rose) and Viola odorata
(sweet violet), Salix alba (white willow)
mixed with small amounts of vinegar
Convolvulus scammonia L. Extracts from Cydonia vulgaris (quince tree),
Rheum ribes (current-fruited rhubarb) and
Rhus coriaria (sumach)
Nerium oleander L.
(Oleander)
Vitis vinifera (common grape), phoenix
dactylifera (dates) and Ficus carica
(wild fig tree)
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Contaminants and adulterants of medicinal plants can be
pharmacologically active and responsible for unexpected
toxicity. Plants may be harvested from contaminated soils or
cleaned improperly such that they may contain illness-
producing microorganisms. Ayurvedic medications have
been known to cause lead poisoning in children because of
their contamination with this heavy metal and others, such as
arsenic and mercury (16,17). Contamination of crop and
medicinal plant samples by organic chemicals has become a
pressing problem in many Arab countries. Low contamination
levels were detected in cucumber and tomato in Palestine,
Jordan and Egypt. Elevated levels of contamination were
detected in vegetables from Pakistan, Egypt and in grapes from
Jordan. Several poisonous cases and plant food contamination
were reported in Morocco, Egypt, Iraq, Saudi Arabia, Sudan,
Syria, Jordan, UAE, Pakistan and Yemen in the past years (18).
For example, Selim and his co-workers (19) found that
common Egyptian foods such as nuts and seeds, cereal grains
were contaminated with aflatoxins. Twenty-nine percent of
medicinal plants were found to be contaminated with aflatoxin
B1. The highest mean concentration of aflatoxin B1 was in
herb and medicinal plants (49 p.p.b.).
Quality Assurance
The increase in popularity has also brought some concerns and
fears over professionalism of practitioners, quality, efficacy
and safety of the ‘natural’ formulations available on the
market. Over the past decade, several newsworthy episodes in
developed as well as developing communities indicated
adverse effects, sometimes life-threatening, allegedly arising
as consequence of taking medicinal plants or traditional
medicines from various ethnic groups (20,21). In some cases,
adulteration, inappropriate formulation or lack of understand-
ing of plant and drug interactions or uses has led to adverse
reactions that are sometimes life-threatening or lethal to
patients (11,22–24). Therefore, for safety and quality assur-
ances, chemical analytical techniques should be applied at
different stages for good practices in quality assurances of
medicinal plants, including good agricultural practice by the
farmers, good sourcing and laboratory practices by the
pharmaceutical companies, good manufacturing practices and
innovative clinical trial practices by researchers and physi-
cians (21,25). We believe that any plant herb or ingredients
taken from plants should be tested before being used as a
remedy. Therefore, various advanced cell biological, bio-
chemical, molecular biological and in vitro cell culture
techniques are applied in our work with different medicinal
herbs in order to test their safety before testing their efficacy
(Table 2).
Hepatotoxicity
Most reports of toxic effects due to the use of herbal medicines
and dietary supplements are associated with hepatotoxicity
(HT) although reports of other toxic effects including kidney,
Production of autocrine
and/or paracrine factors, eg.
Cytokines
Production of systemic
factors, e.g. hormones
Bioactive plant
compounds
- Cell proliferation
- Cell morphology
- Plasma membrane
- Cell signalling
- Cell differentiation
- Metabolism
- DNA replication
- Apoptosis
Target
cell/tissue
Figure 1. Direct and indirect herbal toxicity.
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effects, mutagenicity and carcinogenicity have also been
published in medical literature. Hepatic impairment resulting
from the use of conventional drugs is widely acknowledged,
but there is less awareness of the potential HT of herbal
preparations and other botanicals, many of which are believed
to be harmless and are commonly used for self-medication
without supervision. Although regulation by the Food and
Drug Administration may be part of the solution, increasing
public awareness and education programs for healthcare
professionals about the potential dangers of herbal prepara-
tions will need to be implemented (26,27). The reported
toxicity of herbal formulations may be the result of several
factors, including the contamination with pesticides, microbes,
heavy metals, toxins or adulteration with orthodox drugs
(18,24). On the basis of various case reports, the liver injury
from herbal remedies has ranged from mild elevations of
liver enzymes to fulminated liver failure requiring liver
transplantation (14). For example, veno-occlusive disease
may be caused by pyrrolizidine alkaloids, such as Senecio
species, Heliotropium species and Comfrey (Symphytum
officinale). Chapparal (Larrea divericata) leaf ingestion can
lead to the development of either fulminant hepatic failure or
cirrhosis. Kava (Piper methysticum) has been identified as
causing an acute hepatitis. Many traditional Chinese herbal
preparations have also been described to cause HT and rarely
liver failure (14).
Teratogenic Effects
The effects of contaminations and dosage variations are
higher in children than in adults (14). The teratogenic effects
of herbs are not known in many cases. It is possible that herbal
chemicals may be transported through the placenta to cause
toxic effects on the sensitive growing fetus. For example,
Roulet et al. (15) reported the case of a newborn whose mother
drank senecionine-containing herbal tea daily for the duration
of her pregnancy. The infant was born with hepatic vaso-
occlusive disease and died; senecionine is one of the
pyrrolizidine alkaloids associated with hepatic venous injury.
Safety Evaluation
Tissue Culture Systems
In order to determine the effects of plant extracts, cell culture
model systems are used. In most of these culture systems,
vertebrate cells cultured in vitro have been grown in
monolayer on artificial substrate. However, it has long been
realized that while growth in two dimensions is a convenient
way of preparing and observing a culture and allows a high rate
of cell proliferation, it lacks the cell–cell and cell–substrate
interaction characteristic of whole tissue occurs in vivo. The
interactions of a cell with substratum play an important role in
the development, differentiation and regeneration of multi-
cellular organisms. In cultured rat hepatocytes, morphology,
basal functions such as growth (28,29) or protein synthesis and
secretion (30) are affected by cell–substratum interactions
(29). For toxicity testing in vitro and for studying mechanisms
involved in the response of liver cells to xenobiotics, the
maintenance, expression and regulation of P-450 isoenzymes
is of primary interest (31–33).
Three Dimensional Tissue Cultures
Currently, the available conventional tissue culture polystyr-
ene (TCPS) are not suitable to form tissue-like aggregates
in vitro that require high cell density. In contrast to the in vivo
situation, cells cultured on these flat TCPS built a monolayer
of cells with flat cell morphology. In addition, all cell types,
except those grown in suspension, are in contact with an
environment with some type of topography. The substrate that
shows this topography may be made of other cells or of
extracellular material. Therefore, the engineering of a new
generation of substrates that enables cultured cells to grow at a
higher cell density and to maintain more in vivo like cell-to-
cell interactions is very important in order to obtain more
reliable results in vitro. Therefore, in our cell culture
laboratories, we apply a newly developed cell carrier called
DegraPol. DegraPol represents a versatile biodegradable class
of multiblock copolymeric elastomers. This polymer has been
Table 2. In vitro test methods used in order to evaluate the toxic effects of medicinal plants
Test system End points measured Applications References
MTT Metabolic activity of a mitochondrial
enzyme, succinate dehydrogenase
Cell viability, cell toxicity, cell number 35,36,41,46–48
LDH Lactate dehydrogenase activity Cell viability, toxicity 35,36,41,49–51
Cell counting Cell number Cell proliferation, cytostatic effects 35,36
Trypan blue Trypan blue diffusion into the cells Cell viability 36,52
DNA synthesis 3H-thymidine incorporation or
bromodeoxyuridine (BrdU)
Cell proliferation, cytostatic effects 35,36,53,54
Neutral red uptake Dye uptake Cell proliferation, cytostatic effects 36,43,55
Cell morphology Morphological appearance of cells
and tissues
Cytotoxicity, cell proliferation, cell
differentiation
36,56–58
Protein synthesis 35S-methionine and 3H-prolline; ELISA Cell function 36,39,40,59
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for implantable medical devices (34). Using cell culture
techniques, the newly developed, biodegradable, elastic and
open porous (pore size 200–400 mm) polyesterurethane foams
(DegraPol-foam) were found to be compatible for various
cell types. Macrophages seeded on the DegraPol-foam were
not activated and no cytotoxic effects were detected in these
cells. Osteoblasts and fibroblasts seeded on the DegraPol-foam
showed high cell adhesion and preserved their phenotype
(35–37).
In Vitro Evaluations
For toxicological studies, some of the common standardized
test methods are used in our laboratories. These methods are
based on the extraction of the active compounds. The extracts
are applied to the cells in different dilutions. After exposition
of the cells to the extracts, cytotoxicity is assessed by various
methods, including microscopic evaluation of cell morphol-
ogy, the methyltetrazolium assay (MTT test), measurement of
DNA and protein synthesis, lactate dehydrogenase activity
(LDH), neutral red uptake, and apoptosis tests (36–39). The
MTT and LDH assays are well-established methods used to
assess mitochondrial competence and cell membrane integrity,
respectively (40). The MTT is widely used to assess the
viability and/or the metabolic state of the cells (40). In the
LDH assay the leakage of the cytoplasm located enzyme LDH
into the extracellular medium is measured. The presence of the
exclusively cytosolic enzyme, LDH, in the cell culture
medium is indicative of cell membrane damage (40,60). Using
MTT and the LDH assays, eight plant species used in
traditional Arabic medicine were tested to evaluate their cell
integrity and cytotoxicity using two different types of cultured
cells: rat pheochromocytoma PC12 cells and human hepato-
blastoma HepG2 cells (41).
The results have indicated that the six aqueous plant extracts
(Asphodelus microcarpus, E. creticum, Mercurialis annua,
Rhamnus alaternus, T. polium, Urtica pilulifera) did not
suppress mitochondrial respiration or increase LDH leakage in
PC12 and HepG2 cultured cells with the exception of those
prepared from Ecballium elaterium and Pistacia lentiscus and
only at the higher concentrations, namely 500 and 1000 mg
ml
 1. In a recent study (42) the biosafety of three plant extracts
were evaluated in vitro using co-cultures of cells from the
human hepatocyte cell line (HepG2) and the human monocyte
cell line (THP1). The hepatocyte monoculture was taken as the
control. The monocultures and co-cultures were maintained
under well-controlled in vitro cell culture conditions. Cells
were treated with various concentrations of extracts from
Pistacia palastina, Juglans regia and Quercus ithaburensis.
All three plant extracts exhibited biosafe properties in the
hepatocyte monoculture. In contrast, Pistacia palestina extract
significantly reduced cell viability in co-cultures as measured
with the MTT test and the LDH assay. It seems that the
observed reduction in cell viability in co-culture is a result of
monocyte-derived factors (Fig. 1).
Integration of Tradition with
Modern Technology
Complementary and alternative medicine (CAM) has gained
enormous popularity in our region and worldwide over the past
20 years (43–45,61). This increase in popularity has also
brought some concerns and fears over professionalism of
practitioners, quality, efficacy and safety of the ‘natural’
formulations available on the market. In some cases, adultera-
tion, inappropriate formulation, or lack of understanding of
plant and drug interactions or uses has led to adverse reactions
that are life-threatening or lethal to patients.
Most reports of toxic effects due to the use of herbal
medicines and dietary supplements are associated with HT.
Hepatic impairment resulting from the use of conventional
drugs is widely acknowledged, but there is less awareness of
the potential HT of herbal preparations and other botanicals,
many of which are believed to be harmless and are commonly
used for self-medication without supervision. The reported
toxicity of herbal formulations may be the result of several
factors, including the contamination with pesticides, microbes,
heavy metals, toxins or adulteration with orthodox drugs.
Therefore, for safety and quality assurances, chemical analy-
tical techniques should be applied at different stages for good
practices in quality assurances of natural or herbal remedies,
including good agricultural practice by the farmers, good
Table 3. LD50 values of traditional medicinal plants
Plant species Plant parts
tested
LD50
(g kg
 1 weight)
Alchemilla vulgaris L. (Rosaceae) Leaves 17.3
Atriplex halimus L (Chenopodiaceae) Leaves 21.5
Cichorium pumilum Jacq. (Asteraceae) Leaves 23.6
Crataegus azarolus L. (Rosaceae) Leaves 23.4
Eruca sativa Miller (Brassicaceae) Leaves 21.6
Eryngium creticum Lam. (Apiaceae) Leaves 20.7
Ferula hermonis Boiss (Apiaceae) Roots 8.8
Hypericum triquetrifolium Turra Leaves 14.7
Inula viscosa L. Ait. Inula (Asteraceae) Leaves 11.9
Juglans regia L. (Juglandaceae) Leaves 16.9
Mentha longofolia L. (Lamiaceae) Leaves 14.8
Nigella sativa L. (Ranunculaceae) Seeds 19.8
Olea europaea L. (Oleaceae) Leaves 19.3
Portulaca oleracea L. (Portulacaceae) Above ground
parts
23.8
Saponaria officinalis L.
(Caryophyllaceae)
Roots 5.1
Silene aegyptiaca L. L.f.
(Caryophyllaceae)
Above ground
parts
25.2
Urtica dioica L. (Urticaceae) Leaves 22.1
Ziziphus spina-christi L. Desf.
(Rhamnaceae)
Leaves 22.2
Water extracts prepared from dried plant material were used. Values presented
are means of 30–35 rats tested.
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companies, good manufacturing practices and innovative
clinical trial practices by researchers and physicians.
We believe that any plant herb or ingredients taken from
plants should be tested before being used as a remedy. Hence,
various advanced cell biological, biochemical, molecular
biological and in vitro cell culture techniques should be
applied with different medicinal herbs in order to test their
safety before testing their efficacy. In vitro cell culture
methods have the advantage of relatively well-controlled
variables and are generally accepted as a very effective method
for safety testing. Advantages of such systems over classical
methods (such as long-term studies on experimental animals)
include decreased costs, a reduced time to completion and
reduced numbers of animals necessary to complete the study.
Because of the complicating secondary effects encountered
in vivo, it is often difficult to evaluate the mechanism of action
of an active compound of medicinal plant in a specific cell type
or tissue. The fact that cells and tissues in vivo do not exist in
isolation, but communicate with and are interdependent on
neighboring tissue makes it essential in the research of herbal
remedies and their active compounds in order to simulate the
in vivo situation, where, for example, the microenvironment of
the hepatocytes within the liver acinus involves gradients in
oxygen tension, hormones, extracellular matrix components,
non-parenchymal cells and effective exposure levels of
xenobiotics from the periportal to the pericentral compartment.
Hence, to simulate the in vivo situation a higher degree of
complexity for in vitro methodology is required, such as the
construct of co-cultures.
Future efforts in the development of biosafe and active
medicinal plant compounds will probably be directed towards
the application of modern techniques of cell and molecular
biology to the field of medicinal plant research, such as the
determination of gene activity at both the transcriptional and
translational level is important in the context of mutagenesis
and carcinogenesis. Furthermore, sample preparation is the
crucial first step in the analysis of herbs. Currently, however,
quality-related problems seem to be overshadowing the
potential genuine health benefits of various medicinal plants.
Thus, the development of ‘modern’ sample preparation
techniques with significant advantages over conventional
methods for the extraction and analysis of herbal remedies is
likely to play an important role in the overall effort of ensuring
and providing high-quality medicinal plants to consumers
worldwide. In addition, advances in biotechnology, particu-
larly methods for culturing plant cells and tissues, should
provide new means for the commercial processing of even rare
plants and the chemicals they produce.
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